Runnymede Capital Advisors’s Edwards Lifesciences EW Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-50	Closed	-$3.62K	–	126
2025 Q1	$3.62K	Hold	50	–	–	﹤0.01%	243
2024 Q4	$3.7K	Buy	+50	New	+$3.7K	﹤0.01%	236